Cargando…

Real-life drug retention rate and safety of rituximab when treating rheumatic diseases: a single-centre Swiss retrospective cohort study

BACKGROUND: In Switzerland, rituximab (RTX) is licenced for the treatment of rheumatoid arthritis (RA) and ANCA-associated vasculitis (AAV) but is frequently used off-label to treat other auto-immune diseases (AID), especially connective tissue diseases (CTD). We aimed to characterise the use of RTX...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dumusc, Alexandre, Alromaih, Fahad, Perreau, Matthieu, Hügle, Thomas, Zufferey, Pascal, Dan, Diana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233194/ https://www.ncbi.nlm.nih.gov/pubmed/37264414 http://dx.doi.org/10.1186/s13075-023-03076-w

Ejemplares similares

A prospective evaluation of ultrasound as a diagnostic tool in acute microcrystalline arthritis
por: Pascal, Zufferey, et al.
Publicado: (2015)

Erratum to: A prospective evaluation of ultrasound as a diagnostic tool in acute microcrystalline arthritis
por: Zufferey, Pascal, et al.
Publicado: (2015)

Current perspective on rituximab in rheumatic diseases
por: Schioppo, Tommaso, et al.
Publicado: (2017)

Stem cell transplantation for rheumatic autoimmune diseases
por: Hügle, Thomas, et al.
Publicado: (2008)

Motivational interviewing for prevention in Swiss family medicine: Opportunities and challenges
por: Caiata-Zufferey, Maria, et al.
Publicado: (2023)

Allogeneic stem cell transplantation for rheumatic autoimmune diseases
por: Hügle, Thomas, et al.
Publicado: (2010)

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
por: Avouac, Jérôme, et al.
Publicado: (2021)

Swiss medical centres vary significantly when it comes to outcomes of neonates with a very low gestational age
por: Steurer, Martina A., et al.
Publicado: (2015)

Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event
por: Berger, Joseph R., et al.
Publicado: (2018)

Managing patients with rheumatic diseases treated with rituximab during the COVID-19 pandemic
por: Dougados, Maxime
Publicado: (2021)

An Adherence-Enhancing Program Increases Retention in Care in the Swiss HIV Cohort
por: Kamal, Susan, et al.
Publicado: (2020)

Interchangeability and adverse events in originator-rituximab and its biosimilar (CT-P10) among rheumatic patients: a real-life experience
por: Bahap-Kara, Melda, et al.
Publicado: (2023)

Rituximab in refractory sarcoidosis: a single centre experience
por: Cinetto, Francesco, et al.
Publicado: (2015)

Impulsivity, Depressive Mood, and Cannabis Use in a Representative Sample of French-Speaking Swiss Young Men
por: Rochat, Lucien, et al.
Publicado: (2022)

The Swiss Ecotox Centre: bridging the gap between research and application
por: Werner, Inge
Publicado: (2018)

Off-label use of rituximab in refractory pediatric rheumatic diseases: a single-center experience
por: Aguiar, Francisca, et al.
Publicado: (2014)

Rituximab-Related Late-Onset Neutropenia in Patients with Rheumatic Diseases: Successful Re-Challenge of the Treatment
por: Reitblat, Tatiana, et al.
Publicado: (2015)

Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease
por: Kow, Chia Siang, et al.
Publicado: (2020)

Rituximab-associated hypogammaglobulinemia in autoimmune rheumatic diseases: a single-center retrospective cohort study
por: Wade, Stefanie D., et al.
Publicado: (2021)

Rituximab for interstitial pneumonia with autoimmune features at two medical centres
por: D’Silva, Kristin M, et al.
Publicado: (2021)

Real world data on follicular lymphoma patients treated by rituximab-containing immunochemotherapy and rituximab maintenance
por: Kim, Hee Kyung, et al.
Publicado: (2020)

Idiopathic remitting seronegative symmetrical synovitis with pitting edema syndrome mimicking symptoms of polymyalgia rheumatica: a case report
por: Tarasiuk-Stanislawek, Katarzyna, et al.
Publicado: (2022)

Accidental Hypothermia in a Swiss Alpine Trauma Centre—Not an Alpine Problem
por: Habegger, Katrin, et al.
Publicado: (2022)

Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study
por: Md Yusof, Md Yuzaiful, et al.
Publicado: (2023)

Effect of FCGR polymorphism on the occurrence of late-onset neutropenia and flare-free survival in rheumatic patients treated with rituximab
por: Ajeganova, Sofia, et al.
Publicado: (2017)

Introducing Mushroom Fruiting Patterns from the Swiss National Poisons Information Centre
por: Schenk-Jäger, Katharina M., et al.
Publicado: (2016)

Detection of Chlamydiaceae in Swiss wild birds sampled at a bird rehabilitation centre
por: Stalder, Sandro, et al.
Publicado: (2020)

Rheology of Swiss Cheese Fondue
por: Bertsch, Pascal, et al.
Publicado: (2019)

Favorable retention rates and safety of conventional anti-rheumatic drugs in older patients with rheumatoid arthritis
por: Alpay-Kanitez, Nilüfer, et al.
Publicado: (2020)

Real world evidence: Patients with refractory pemphigus treated with Rituximab
por: Perifani, Vagiani, et al.
Publicado: (2021)

Real-world experience of rituximab biosimilar GP2013 in rheumatoid arthritis patients naïve to or switched from reference rituximab
por: Łosińska, Katarzyna, et al.
Publicado: (2023)

The Cumulative Impact of Harm Reduction on the Swiss HIV Epidemic: Cohort Study, Mathematical Model, and Phylogenetic Analysis
por: Marzel, Alex, et al.
Publicado: (2018)

Interest in and use of person-centred pharmacy services - a Swiss study of people with diabetes
por: Bawab, Noura, et al.
Publicado: (2021)

Low occurrence of Salmonella spp. in wild birds from a Swiss rehabilitation centre
por: Vogler, Barbara R., et al.
Publicado: (2021)

Swiss Implementation Science Network (IMPACT): A Crucial Building Block to Strengthen the Swiss Research Pipeline for Real-World Translation
por: Dhaini, Suzanne R., et al.
Publicado: (2021)

Comparable long-term retention rates and effects on bone mineral density of denosumab treatment in patients with osteoporosis with or without autoimmune inflammatory rheumatic diseases: real-life data
por: Fassio, Angelo, et al.
Publicado: (2022)

Effect of national HIV testing recommendations and local interventions on HIV testing practices in a Swiss university hospital: a retrospective analysis between 2012 and 2015
por: Lazzarino, Tosca, et al.
Publicado: (2018)

When science takes centre stage
Publicado: (2005)

Improvement in rheumatic fever and rheumatic heart disease management and prevention using a health centre-based continuous quality improvement approach
por: Ralph, Anna P, et al.
Publicado: (2013)

Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease: Data from the Swiss Clinical Quality Management cohort
por: Hebeisen, Monika, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_svbvga3e4brn5gc8sca7ai1fqa